OPTIMIZATION OF PAIN THERAPY IN PATIENTS WITH DIABETIC POLYNEUROPATHY: NEW APPROACHES AND PERSPECTIVES
Bulletin of medicine, psychology and pharmacy · 2025
DOI: 10.20998/bmpp.2024.01.09 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bulletin of medicine, psychology and pharmacy, 2025. Verfasst von Vasyl Hrabar und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction. Diabetic sensorimotor polyneuropathy is one of the most common complications of diabetes mellitus, which increases the risk of mortality, worsens the quality of life, and increases the economic costs of treating pain or managing diabetic foot. Diabetic polyneuropathy remains a challenge for physicians due to the wide range of medications and alternative treatments, most of which are not effective in clinical trials and do not meet the tenets of evidence-based medicine. The purpose of the study was to analyze and systematize the data from the current literature in the framework of evidence-based medicine for the treatment of diabetic polyneuropathy. The literature data were analyzed, and information from articles was extracted and annotated using the PubMed biomedical research search engine for the effectiveness of drug and non-drug treatment of this problem. It has been established that adequate glycaemic control reduces the progression of complications, especially in type 1 diabetes mellitus. Clinical trials do not confirm the effectiveness of pathogenetic therapy in combating the consequences of diabetes, so due to the lack of evidence, it is not yet advisable to recommend this range of drugs for the prevention of diabetes complications. The main disabling factor in diabetic polyneuropathy is neuropathic pain, which, in combination with microvascular complications, significantly worsens the patient's quality of life. Anticonvulsants, antidepressants, and occasionally opioids remain the leaders among evidence-based drug therapies for neuropathic pain. Non-pharmacological therapy in the form of physical, mechanical, and chemical methods of influencing the human body, in particular the affected nerves, can be recommended as an addition to drug therapy to alleviate pain. The work is aimed mainly at practitioners to familiarise them with the current international understanding of this problem and ways to combat it.
Zitieren
APA
Hrabar, V., Smolanka, V., Buletsa, B., Pulyk, O., Pukaliak, I., & Sofilkanych, N. (2025). OPTIMIZATION OF PAIN THERAPY IN PATIENTS WITH DIABETIC POLYNEUROPATHY: NEW APPROACHES AND PERSPECTIVES. Bulletin of medicine, psychology and pharmacy. https://doi.org/10.20998/bmpp.2024.01.09
Vancouver
Hrabar V, Smolanka V, Buletsa B, Pulyk O, Pukaliak I, Sofilkanych N. OPTIMIZATION OF PAIN THERAPY IN PATIENTS WITH DIABETIC POLYNEUROPATHY: NEW APPROACHES AND PERSPECTIVES. Bulletin of medicine, psychology and pharmacy. 2025. doi:10.20998/bmpp.2024.01.09
BibTeX
@article{Hrabar2025,
author = {Hrabar, Vasyl and Smolanka, Volodymyr and Buletsa, Bohdan and Pulyk, Oleksandr and Pukaliak, Iryna and Sofilkanych, Nina},
title = {OPTIMIZATION OF PAIN THERAPY IN PATIENTS WITH DIABETIC POLYNEUROPATHY: NEW APPROACHES AND PERSPECTIVES},
journal = {Bulletin of medicine, psychology and pharmacy},
year = {2025},
doi = {10.20998/bmpp.2024.01.09}
}
EUVIMED